HomeInsightsStock Comparison

Dr Lal Pathlabs Ltd vs Syngene International Ltd Stock Comparison

Dr Lal Pathlabs Ltd vs Syngene International Ltd Stock Comparison

Last Updated on: Jun 15, 2025

Key Highlights

  • The Latest Trading Price of Dr Lal Pathlabs Ltd is ₹ 2954 as of 13 Jun 15:30.
  • The P/E Ratio of Dr Lal Pathlabs Ltd changed from 51.7 on March 2020 to 42.5 on March 2025 . This represents a CAGR of -3.21% over 6 yearsThe P/E Ratio of Syngene International Ltd changed from 23.5 on March 2020 to 0 on March 2025 . This represents a CAGR of -100.00% over 6 years.
  • The Market Cap of Dr Lal Pathlabs Ltd changed from ₹ 11679 crore on March 2020 to ₹ 20714 crore on March 2025 . This represents a CAGR of 10.02% over 6 yearsThe Market Cap of Syngene International Ltd changed from ₹ 9662 crore on March 2020 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 6 years.
  • The revenue of Dr Lal Pathlabs Ltd for the Mar '25 is ₹ 628.4 crore as compare to the Dec '24 revenue of ₹ 621.8 crore. This represent the growth of 1.06% The revenue of Syngene International Ltd for the Mar '25 is ₹ 1036 crore as compare to the Dec '24 revenue of ₹ 962 crore. This represent the growth of 7.79%.
  • The ebitda of Dr Lal Pathlabs Ltd for the Mar '25 is ₹ 194.8 crore as compare to the Dec '24 ebitda of ₹ 179.1 crore. This represent the growth of 8.77% The ebitda of Syngene International Ltd for the Mar '25 is ₹ 362.5 crore as compare to the Dec '24 ebitda of ₹ 301.9 crore. This represent the growth of 20.07%.
  • The net profit of Dr Lal Pathlabs Ltd changed from ₹ 83.6 crore to ₹ 155.5 crore over 8 quarters. This represents a CAGR of 36.38% The net profit of Syngene International Ltd changed from ₹ 93.4 crore to ₹ 183.3 crore over 8 quarters. This represents a CAGR of 40.09% .
  • The Dividend Payout of Dr Lal Pathlabs Ltd changed from 49.24 % on March 2020 to 40.34 % on March 2025 . This represents a CAGR of -3.27% over 6 yearsThe Dividend Payout of Syngene International Ltd changed from 10.18 % on March 2022 to 0 % on March 2025 . This represents a CAGR of -100.00% over 4 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Dr Lal Pathlabs Ltd

  • Dr. Lal PathLabs Limited was incorporated as a Private Limited Company with the name Dr. Lal PathLabs Private Limited', on February 14, 1995 at Delhi.
  • The business of the Partnership Firm, Central Clinical Laboratory was undertaken by the Company.
  • The Company converted into a Public Limited Company and name of the Company was changed to Dr. Lal PathLabs Limited' vide fresh Certificate of Incorporation granted by the RoC on August 19, 2015. Dr Lal PathLabs is among the most trusted diagnostic healthcare service provider in India, offering services through over 5000 diagnostic tests and related healthcare services through a nationwide network of medical laboratory centres.
  • Through its integrated, nationwide network, the Company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

About Syngene International Ltd

  • Syngene International Limited is an integrated research, development and manufacturing services organization serving global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors.
  • Headquartered in India, the operations are driven by its highly qualified teams comprising ~6000 scientists and its state-of-the-art facilities, spread over 2.2 million sq. ft., across 3 locations in India: Bangalore, Hyderabad and Mangalore.
  • The Company operate into 4 business divisions comprising of Discovery Services, Development Services, Manufacturing Services and the Dedicated Centers. Syngene International Limited was incorporated at Bangalore in 1993.
  • The Company was promoted by Biocon and Kiran Mazumdar Shaw, a promoter of Biocon Limited.
  • The Company's health-related services extend across all major therapeutic areas and modalities.

Dr Lal Pathlabs Ltd News Hub

News

Board of Dr. Lal PathLabs recommends final dividend

Dr. Lal PathLabs announced that the Board of Directors of the Company at its meeting held ...

Read more

25 Apr 2025 15:23

News

Dr. Lal PathLabs to convene AGM

Dr. Lal PathLabs announced that the Annual General Meeting(AGM) of the company will be hel...

Read more

25 Apr 2025 15:23

News

Dr. Lal PathLabs schedules board meeting

Dr. Lal PathLabs will hold a meeting of the Board of Directors of the Company on 25 April ...

Read more

19 Apr 2025 10:39

News

Dr Lal Pathlabs introduces highly specialized Amyloidosis test

Dr Lal Pathlabs has introduced Amyloid Typing by Laser Capture Microdissection & Mass Spec...

Read more

15 Apr 2025 14:09

News

Dr Lal Pathlabs Ltd leads losers in 'A' group

Aditya Birla Real Estate Ltd, Can Fin Homes Ltd, Paisalo Digital Ltd and Religare Enterpri...

Read more

25 Feb 2025 15:00

News

Dr Lal Pathlabs allots 4,000 equity shares under ESOP

Dr Lal Pathlabs has allotted 4,000 equity shares under ESOP on 18 February 2025. With this...

Read more

18 Feb 2025 18:20

Syngene International Ltd News Hub

News

Syngene's Bengaluru-based facility gets 'NAi' status from US FDA

The inspection concluded successfully, with the facility found to be in compliance with th...

Read more

14 Jun 2025 14:28

News

Syngene International to conduct AGM

Syngene International announced that the 32nd Annual General Meeting(AGM) of the company w...

Read more

24 Apr 2025 11:30

News

Board of Syngene International recommends final dividend

Syngene International announced that the Board of Directors of the Company at its meeting ...

Read more

24 Apr 2025 10:43

News

Volumes spurt at Syngene International Ltd counter

Natco Pharma Ltd, Newgen Software Technologies Ltd, MMTC Ltd, Glaxosmithkline Pharmaceutic...

Read more

24 Apr 2025 14:30

News

Syngene International Ltd leads losers in 'A' group

Nava Ltd, 360 ONE WAM Ltd, KFin Technologies Ltd and Can Fin Homes Ltd are among the other...

Read more

24 Apr 2025 15:00

News

Syngene slides on tepid results and toned-down forecast

On a consolidated basis, net profit of Syngene International declined 2.81% to Rs 183.30 c...

Read more

24 Apr 2025 16:22

SWOT Analysis Of Syngene International Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Dr Lal Pathlabs Ltd

Strength

6

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Syngene International Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Dr Lal Pathlabs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Dr Lal Pathlabs Ltd and Syngene International Ltd

Which company has a larger market capitalization, Dr Lal Pathlabs Ltd or Syngene International Ltd?

Market cap of Dr Lal Pathlabs Ltd is 24,747 Cr while Market cap of Syngene International Ltd is 26,291 Cr

What are the key factors driving the stock performance of Dr Lal Pathlabs Ltd and Syngene International Ltd?

The stock performance of Dr Lal Pathlabs Ltd and Syngene International Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Dr Lal Pathlabs Ltd and Syngene International Ltd?

As of June 15, 2025, the Dr Lal Pathlabs Ltd stock price is INR ₹2954.0. On the other hand, Syngene International Ltd stock price is INR ₹652.5.

How do dividend payouts of Dr Lal Pathlabs Ltd and Syngene International Ltd compare?

To compare the dividend payouts of Dr Lal Pathlabs Ltd and Syngene International Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions